Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Article
  • Published:

Recombinant Sendai virus provides a highly efficient gene transfer into human cord blood-derived hematopoietic stem cells

Abstract

Hematopoietic stem cells (HSCs) are a promising target for gene therapy, however, the low efficiencies of gene transfer using currently available vectors face practical limitations. We have recently developed a novel and efficient gene transfer agent, namely recombinant Sendai virus (SeV), and we have here characterized SeV-mediated gene transfer to human cord blood (CB) HSCs and primitive progenitor cells (PPC) using the jelly fish green fluorescent protein (GFP) gene. Even at a relatively low titer (10 multiplicity of infections), SeV achieved highly efficient GFP expression in CB CD34+ cells (85.5±5.8%), as well as more immature CB progenitor cells, CD34+AC133+ (88.2±3.7%) and CD34+CD38 (84.6±5.7%) cells, without cytokines prestimulation, that was a clear contrast to the features of gene transfer using retroviruses. SeV-mediated gene transfer was not seriously affected by the cell cycle status. In vitro cell differentiation studies revealed that gene transfer occurred in progenitor cells of all lineages (GM-CFU, 73.0±11.1%; BFU-E, 24.7±4.0%; Mix-CFU, 59±4.0%; and total, 50.0±7.0%). These findings show that SeV could prove to be a promising vector for efficient gene transfer to CB HSCs, while preserving their ability to reconstitute the entire hematopoietic series.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Yonemitsu Y et al. Efficient gene transfer to airway epithelium using recombinant Sendai virus. Nat Biotechnol 2000; 18: 970–973.

    Article  CAS  PubMed  Google Scholar 

  2. Masaki I et al. Recombinant Sendai virus-mediated gene transfer to vasculature: a new class of efficient gene transfer vector to the vascular system. FASEB J 2001; 15: 1294–1296.

    Article  CAS  PubMed  Google Scholar 

  3. Shiotani A et al. Skeletal muscle regeneration after insulin-like growth factor I gene transfer by recombinant Sendai virus vector. Gene Ther 2001; 8: 1043–1050.

    Article  CAS  PubMed  Google Scholar 

  4. Yamashita A et al. Fibroblast growth factor-2 determines severity of joint disease in adjuvant-induced arthritis in rats. J Immunol 2002; 168: 450–457.

    Article  CAS  PubMed  Google Scholar 

  5. Markwell MA, Svennerholm L, Paulson JC . Specific gangliosides function as host cell receptors for Sendai virus. Proc Natl Acad Sci USA 1981; 78: 5406–5410.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Moyer SA, Baker SC, Lessard JL . Tubulin: a factor necessary for the synthesis of both Sendai virus and vesicular stomatitis virus RNAs. Proc Natl Acad Sci USA 1986; 83: 5405–5409.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Gothot A et al. Assessment of proliferative and colony-forming capacity after successive in vitro divisions of single human CD34+ cells initially isolated in G0 . Exp Hematol 1998; 26: 562–570.

    CAS  PubMed  Google Scholar 

  8. Becker PS et al. Adhesion receptor expression by hematopoietic cell lines and murine progenitors: modulation by cytokines and cell cycle status. Exp Hematol 1999; 27: 533–541.

    Article  CAS  PubMed  Google Scholar 

  9. Gonzalez R et al. Increased gene transfer in acute myeloid leukemic cells by an adenovirus vector containing a modified fiber protein. Gene Ther 1999; 6: 314–320.

    Article  CAS  PubMed  Google Scholar 

  10. Huang S, Endo RI, Nemerow GR . Upregulation of integrins alpha v beta 3 and alpha v beta 5 on human monocytes and lymphocytes facilitates adenovirus-mediated gene delivery. J Virol 1995; 69: 2257–2263.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Bodine DM, McDonagh KT, Seidel NE, Nienhuis AW . Survival and retrovirus infection of murine hematopoietic stem cells in vitro: effects of 5-FU and method of infection. Exp Hematol 1991; 19: 206–212.

    CAS  PubMed  Google Scholar 

  12. Tumas DB et al. High-frequency cell surface expression of a foreign protein in murine hematopoietic stem cells using a new retroviral vector. Blood 1996; 87: 509–517.

    CAS  PubMed  Google Scholar 

  13. Cavazzana-Calvo M et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 2000; 28: 669–672.

    Article  Google Scholar 

  14. Luther-Wyrsch A et al. Stable transduction with lentiviral vectors and amplification of immature hematopoietic progenitors from cord blood of preterm human fetuses. Hum Gene Ther 2001; 12: 377–389.

    Article  CAS  PubMed  Google Scholar 

  15. Gothot A et al. Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34+ cells in non-obese diabetic/severe combined immune-deficient mice. Blood 1998; 92: 2641–2649.

    CAS  PubMed  Google Scholar 

  16. Kato A et al. The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis. EMBO J 1997; 16: 578–587.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Bitzer M et al. Sendai virus infection induces apoptosis through activation of caspase-8 (FLICE) and caspase-3 (CPP32). J Virol 1999; 73: 702–708.

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Kato A et al. Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense. Genes Cells 1996; 1: 569–579.

    Article  CAS  PubMed  Google Scholar 

  19. Sakai Y et al. Accommodation of foreign genes into the Sendai virus genome: sizes of inserted genes and viral replication. FEBS Lett 1999; 456: 221–226.

    Article  CAS  PubMed  Google Scholar 

  20. Kolakofsky D et al. Paramyxovirus RNA synthesis and the requirement for hexamer genome length: the rule of six revisited. J Virol 1998; 7: 891–899.

    Google Scholar 

  21. Fuerst TR, Niles EG, Studier FW, Moss B . Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc Natl Acad Sci USA 1986; 83: 8122–8126.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Yonemitsu Y, Kaneda Y . Hemagglutinating virus of Japan-liposome-mediated gene delivery to vascular cells. In: Baker AH (ed.). Molecular Biology of Vascular Diseases. Methods in Molecular Medicine. Humana Press: Clifton, 1999, pp 295–306.

    Google Scholar 

  23. Jordan CT, Yamasaki G, Minamoto D . High-resolution cell cycle analysis of defined phenotypic subsets within primitive human hematopoietic cell populations. Exp Hematol 1996; 24: 1347–1355.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Dr Kusuo Sanada for providing cord blood samples. This study was supported by a Grant of Promotion of Basic Scientific Research in Medical Frontier of the Organization for Pharmaceutical Safety and Research, and by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. M Ohara provided language assistance.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jin, C., Kusuhara, K., Yonemitsu, Y. et al. Recombinant Sendai virus provides a highly efficient gene transfer into human cord blood-derived hematopoietic stem cells. Gene Ther 10, 272–277 (2003). https://doi.org/10.1038/sj.gt.3301877

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3301877

Keywords

This article is cited by

Search

Quick links